Tumor bone diseases: molecular mechanisms and opportunities for novel treatments.

Susa, M; Glatt, M; Teti, A

Susa, M; Glatt, M; Teti, A.

Affiliation

Susa M; Department of Experimental Medicine, University of L'Aquila, L'Aquila, Italy.

Curr Med Chem Anticancer Agents ; 1(3): 313-29, 2001 Nov.

Article in En | MEDLINE | ID: mdl-12678761

Subject(s)

Bone Neoplasms/drug therapy; Bone Neoplasms/genetics; Animals; Bone Neoplasms/pathology; Bone Neoplasms/secondary; Bone and Bones/cytology; Bone and Bones/physiology; Enzyme Inhibitors/chemical synthesis; Enzyme Inhibitors/pharmacology; Humans; Neoplasm Metastasis/pathology; Receptors, Cell Surface/drug effects; Receptors, Cell Surface/physiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms Limits: Animals / Humans Language: En Journal: Curr Med Chem Anticancer Agents Journal subject: ANTINEOPLASICOS / QUIMICA Year: 2001 Document type: Article Affiliation country: Italy Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links